ArticleJournal of thoracic disease2019

Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy.

Chiara Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.